Drug-induced movement disorders in children

Area of Science:

• Pediatric Neurology
• Clinical Pharmacology
• Adverse Drug Reactions

Background:

• Drug-induced movement disorders (DIMDs) are a significant concern in pediatric populations.
• Prescription rates for dopaminergic and dopamine-blocking agents, common causes of DIMDs, have notably increased in children.
• Existing literature often lacks robust systematic data, relying heavily on case series.

Purpose of the Study:

• To review the current knowledge on DIMDs in pediatric patients.
• To assist clinicians and specialists in managing and diagnosing DIMDs in children.
• To highlight the limitations in current evidence regarding pediatric DIMDs.

Main Methods:

• Comprehensive literature review of drug-induced movement disorders in children.
• Analysis of available evidence, including case series and systematic reviews.
• Focus on medications commonly implicated in pediatric DIMDs.

Main Results:

• Dopaminergic and dopamine-blocking medications are the most frequent culprits for DIMDs in children.
• A significant increase in the use of these medications among pediatric patients has been observed.
• Systematic data for evidence-based reviews are scarce, with many studies being small case series.

Conclusions:

• Clinicians require updated information on DIMDs to effectively manage pediatric patients.
• The current evidence base for pediatric DIMDs is limited, necessitating cautious interpretation.
• Further systematic research is crucial to better understand and treat DIMDs in children.